1). The use of IL-12p40-deficient mice or neutralizing Abs against IL-12p40 was among the most powerful interventions to prevent experimental autoimmunity [23]. The discovery of IL-23 and its use of the p40 subunit opened up the possibility that attributing auto-inflammatory disease initiation anti-CTLA-4 antibody to

IL-12 and Th1 cells may have been based on mistaken identity. Shortly after the discovery of IL-23, it was shown that mice lacking IL-12 (p35) were highly susceptible to experimental autoimmune encephalomyelitis (EAE), whereas IL-12/23p40-deficient mice were indeed completely resistant [24]. This observation caused a paradigm shift, and the fundamental role of IL-23 rather than IL-12 as a master regulator in autoimmune disease was confirmed when mice lacking the unique IL23p19 subunit were found to phenocopy IL-12/23p40−/− mice [25]. Contrary to IL-12, IL-23 does not induce the differentiation of IFN-γ-producing Th1 cells, but drives the expansion of a highly encephalitogenic, IL-17-producing T-cell population [26]. This was among the most exciting among a fine selection of observations made in the

long history of studying the functions AZD1208 purchase of IL-12 and IL-23 (Fig. 1), and has in itself spawned a new field of research dedicated to unraveling the regulation and function of IL-17-producing helper T cells, so called “Th17” cells. While IL-12 can be sensed by naïve cells, the complete IL-23 receptor is not expressed on their surfaces. Thus, ID-8 the factors equipping T cells with the ability to sense IL-23 became a major focus of research (reviewed in [27]). Much like the cytokines of the IL-12 family, the corresponding IL-23 receptors also share subunits that are required for the signaling of multiple cytokines. The IL-23 receptor is composed of a common

subunit, IL-12Rβ1, and a second protein unique to IL-23 signaling, IL-23Rα [28]. IL-12Rβ1 is also required for IL-12 signaling, but to date the only known function of the IL-23Rα chain is to transmit the signals of IL-23. Therefore, T cells lacking IL-12Rβ1 cannot respond to IL-12 nor IL-23. T cells lacking IL-23Rα cannot respond to IL-23, but retain IL-12 signaling capability. In the context of the widely used animal model for multiple sclerosis, EAE, deficiency of IL-12Rβ1 completely abrogates disease induction [29]. The observation that IL-12Rβ2-deficient mice are fully susceptible to EAE confirms that IL-12 signaling is dispensable for EAE induction, and the missing signals from IL-23 are responsible for the resistance seen in IL-12Rβ1 knockouts [30]. IL-23 was soon after definitively confirmed as the major pathogenic molecule in EAE, due to a requirement for IL-23 signals to drive proliferation, expansion, and survival of pathogenic T cells in the CNS [25, 31].